Akoya is updating its revenue outlook for the full year 2024 while maintaining its commitment to achieving operating cash flow breakeven by year end. The company now expects the full year 2024 revenue to be in the range of $96-104M.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AKYA:
- AKYA Upcoming Earnings Report: What to Expect?
- Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences
- Craig-Hallum starts Akoya with a Buy, says shares ‘significantly’ undervalued
- Akoya Biosciences initiated with a Buy at Craig-Hallum
- Akoya Biosciences management to meet virtually with BTIG